A comprehensive view of Hospital / Clinical Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Innoviva's Xacduro gains FDA approval to treat hospital-acquired and ventilator-associated bacterial pneumonia caused by Acinetobacter baumannii-calcoaceticus complex; WHO reports Acinetobacter is the highest-risk bacterial pathogen for human health
Published:
May 25, 2023
by MarketLine
|
Fresenius Kabi, a provider of injectable medications, launches Rocuronium Bromide Injection with advanced RFID-enabled labels, its first product compatible with Bluesight’s KitCheck System, a kit and tray solution for hospitals allowing use of RFID
Published:
May 24, 2023
by Kit Check Inc.
|
Pfizer warns Indian clinicians to stop using four antibiotics due to manufacturing issues at contract producer Astral Steritech; drugs include Magnex, Zosyn, Magnamycin and Magnex Forte
Published:
May 18, 2023
by FiercePharma
|
AstraZeneca refreshes Fasenra asthma drug marketing to offer consistent messaging to physicians and patients for the first time; 'Move Forward' campaign pairs consumer-focused message with materials aimed at doctors
Published:
May 17, 2023
by FiercePharma
|
Executive Perspective: Pfizer CEO calls US plan to negotiate Medicare drug prices 'negotiation with a gun to your head' and expects legal action from drug industry; US seeks to save US$25B by 2031 with drug pricing reform plan
Published:
May 12, 2023
by Zawya
|
Ask us about our Tissue & Hygiene market view
Trending Chart
Interactive chart with headline count